Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

GM2-KLH vaccine

A cancer vaccine consisting of GM2 ganglioside, a melanoma-specific antigen, conjugated with the immunostimulant keyhole limpet hemocyanin. Vaccination with GM2-KLH vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against GM2 ganglioside-expressing melanoma cells, resulting in tumor growth inhibition.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:GM2-KLH ganglioside
KLH-conjugated GM2 Ganglioside Vaccine
Abbreviation:GM2-KLH
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search